Soliton's gross profit is $26K, below the Healthcare sector average of $65B.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2021
Trailing 12 months ending Sep 30, 2021
The latest gross profit for SOLY is $26K as of September 2021. In the prior-year period, the figure was $0. That is below the Healthcare sector average of $65B. Investors often review this figure alongside Soliton's historical trend and sector peers before judging valuation or financial health.
Over the past year, SOLY's gross profit moved from $0 to $26K. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Soliton's operating scale or balance-sheet position.
Against Healthcare companies, SOLY currently prints $26K for gross profit, while the sector average sits near $65B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Soliton's growth, margins, and balance sheet.
A gross profit figure of $26K for SOLY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $65B. Explore the charts below for those layers of context.
After noting SOLY's gross profit ($26K), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.